美女免费一级视频在线观看
Tremfya snagged Dupixent’s place as the pharma brand with the most TV impressions in June, according to data released by iSpot.tv on Friday morning.
The Johnson & Johnson brand garnered a 4.3% share of voice (SOV) and tied with Dupixent’s impressions last month at 2.5 billion. Tremfya’s total estimated national TV ad spend was $27.6 million.
Meanwhile, Dupixent fell to the seventh spot with a 2.82% SOV, 1.6 billion impressions, and an estimated national TV ad spend of $13.8 million. The brand spent roughly $14.4 million less than in May.
AbbVie’s Skyrizi maintained its No. 2 spot with a small increase in SVO from 3.78% in May to 3.95% in June. The psoriasis treatment spent roughly $30.3 million on TV ad spends and reached 2.3 billion impressions.
Both Tremfya and Skyrizi benefitted the most from ABC’s ABC World News Tonight with David Muir, which was the top programming in June. News programming overall was the key driver of reach for pharma.
Haleon’s Advil and Novo Nordisk’s Wygovy rose from the bottom half to the top half of the ranks in June, taking the third and fourth spots. Advil’s SOV was 3.69% with 2.1 billion impressions and $7.9 million on TV ad spend. Its top network was CNN and the top program was The Big Bang Theory.
Wygovy’s SOV was 3.6% with 2.1 billion impressions and $39.9 million in TV ad spend. Its top network was CBS and the top program was Gunsmoke.
In the fifth spot is AbbVie’s Rinvoq, which fell from fourth place in May. It spent $28 million on TV ad spend this month, up from $26.6 million in May. It maintained similar impressions with 1.8 billion in June versus 1.9 billion in May. However, its SOV rose from 2.91% in May to 3.18% in June.
The bottom half of the rank includes Rexulti, which fell from fifth place in May to six place in June, as well as Dupixent, Iberogast, MiraLAX, and Bausch + Lomb Blink.
Last month, Iberogast had the lowest national TV ad spend among the top 10, which rose this month to
$3.7 million. This month, MiraLAX had the lowest spend at $3 million.
Afrin and Claritin fell off of the list this month, being replaced by MiraLAX and Bausch + Lomb Bling, who ranked ninth and tenth.
News programming provided the largest reach for pharma, along with cable news and sports-focused programs. NCIS and Law and Order: Special Victims Unit were two of the most cost-effective programs this month.
“Pharma brands continue to lean heavily on the news genre to drive reach, with both broadcast and cable news programs seeing notable year-over-year growth. But syndicated daytime like Law & Order: SVU and The Big Bang Theory, are also delivering cost-efficient avenues for connecting with broad audiences, and pharma advertisers are taking notice,” said Tyler Bobin, senior brand analyst at iSpot.